Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-05-21
1993-07-20
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61U 31505
Patent
active
052293890
ABSTRACT:
The invention concerns the use of i.a. 1-[2-(2-naphthyl)-ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyr idine and its pharmaceutically acceptable addition salts for the preparation of medicaments suitable for the treatment and/or prophylaxis of neuronal degenerative processes including senile dementia, vascular dementia, and Alzheimer's disease.
REFERENCES:
patent: 4521428 (1985-06-01), Nisato et al.
Chem. Abst. 114-157215u (1991).
D H H S Publication (ADM) 90-1699 (1990) "Useful Information on Alzheimer's Disease".
Coude Francois X.
Fournier Jacqueline
Guzzi Umberto
Friedman S. J.
Sanofi
LandOfFree
Method for evaluating neuronal activity of a drug does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for evaluating neuronal activity of a drug, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for evaluating neuronal activity of a drug will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1760680